We are updating the osteoporosis guideline to bring all NICE recommendations into one comprehensive resource. The revised guidance will be delivered in two parts:
Part 1: will cover identifying adults who should be assessed for fragility fracture risk, methods of risk assessment, identifying vertebral fractures, treatment criteria and repeat risk assessment (timing and methods) for people not receiving treatment.
Part 2: will cover risk assessment for people with a learning disability, treatment (pharmacological, exercise and calcium and vitamin D), monitoring of treatment and treatment pauses, incorporating recommendations from a new Multiple Technology Appraisal (MTA) to create a single set of pharmacological treatment guidelines.
The Stakeholder consultation on Part 1 and the consultation on the MTA scope runs from 13 January to 23 February 2026.
- Status:
- In progress
- Developed as:
- CG
Provisional Schedule
- Draft guidance consultation:
- 13 January 2026 - 23 February 2026
- Expected publication:
- 15 July 2026
Email enquiries
If you have any queries please email osteoporosis@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 18 November 2024 | Declaration of interests |
| 11 July 2024 | Stakeholder list updated |
| 27 June 2024 | Committee list updated |
| 20 February 2023 | Scope published |
| 02 February 2023 | Committee meeting |
| 27 October 2022 - 01 December 2022 | Draft scope consultation |
| 27 October 2022 - 24 November 2022 | Committee member recruitment |
| 22 November 2022 | Scope consultation end date extended by one week from 24/11/2022 until 01/12/2022. |
For further information on the guideline development process, please see how we develop NICE guidelines